Skip to main content
Tempus AI10-K: Product launch

Tempus launching new AI-driven diagnostic products, including 'Next' and 'Algos'.

What happened

Tempus is focused on commercializing new AI-based products like 'Next' for oncology/cardiology care gaps and 'Algos' for algorithmic diagnostics.

Source

SEC EDGARFeb 24, 2026

Annual report (Form 10-K)

Tempus AI 10-K for FY2025

Filing excerpt

Next is an AI platform that leverages machine learning to apply an “intelligent layer” onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.

sec.gov/Archives/edgar/data/1717115/000119312526066961/tem-20251231.htmRead the full source

Other signals in this filing (10)

Extracted by Autobound

From the Signal API record
Signal
10-K: Product launch

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/31
Filed
Feb 24, 2026

More 10-K signals at other companies

The full record

From the Signal API record

Details

CIK
1717115
Accession number
0001193125-26-066961
Filing year
2026
Why it matters
Go-to-market support
Signal category
Strategic

Topics and mentions

Technologies

  • AI
  • machine learning
  • generative AI

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
Mar 3, 2026
signal_type
sec-10k
signal_subtype
productLaunch

Use this data

Get every 10-K signal for Tempus AI and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Tempus AI this week?”

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/5e73c3ee-94e1-4aed-857e-085c2521512f returns this record as JSON. POST /v1/companies/enrich returns every signal for tempus.com.

{
  "signal_id": "5e73c3ee-94e1-4aed-857e-085c2521512f",
  "signal_type": "sec-10k",
  "signal_subtype": "productLaunch",
  "detected_at": "2026-03-03T06:07:15.511+00:00",
  "company": {
    "name": "Tempus AI",
    "domain": "tempus.com"
  },
  "data": {
    "detail": "Tempus is focused on commercializing new AI-based products like 'Next' for oncology/cardiology care gaps and 'Algos' for algorithmic diagnostics. This indicates R&D and go-to-market budget allocation for new product lines, creating opportunities for development, marketing, and sales support vendors.",
    "summary": "Tempus launching new AI-driven diagnostic products, including 'Next' and 'Algos'.",
    "excerpts": "Next is an AI platform that leverages machine learning to apply an “intelligent layer” onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1717115/000119312526066961/tem-20251231.htm",
    "filing_date": "2026-02-24",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Go-to-market support",
    "signal_category": "strategic",
    "technologies_mentioned": [
      "AI",
      "machine learning",
      "generative AI"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.